Table 2.

Types of patients having antiphospholipid (aPL) antibodies.

  • Antiphospholipid syndrome

    • “Primary” – in the absence of SLE

    • “Secondary” – in patients with SLE

  • aPL antibodies stimulated by infection

    • No known association with thrombosis (e.g., syphilis, Lyme disease, cytomegalovirus, Epstein-Barr virus)

    • Possible association with thrombosis (e.g., varicella, HIV, hepatitis C)

  • Drug-induced aPL antibodies (e.g. chlorpromazine and other phenothiazines)

  • aPL antibodies prevalent in the general population

 
  • Antiphospholipid syndrome

    • “Primary” – in the absence of SLE

    • “Secondary” – in patients with SLE

  • aPL antibodies stimulated by infection

    • No known association with thrombosis (e.g., syphilis, Lyme disease, cytomegalovirus, Epstein-Barr virus)

    • Possible association with thrombosis (e.g., varicella, HIV, hepatitis C)

  • Drug-induced aPL antibodies (e.g. chlorpromazine and other phenothiazines)

  • aPL antibodies prevalent in the general population

 
Close Modal

or Create an Account

Close Modal
Close Modal